Hypoxia is considered one of microenvironmental factors associated with the malignant nature of glioblastoma. Thus, evaluating intratumoral distribution of hypoxia would be useful for therapeutic planning as well as assessment of its effectiveness during the therapy. Electron paramagnetic resonance imaging (EPRI), is an imaging technique which can generate quantitative maps of oxygen in vivo using the exogenous paramagnetic compound, triarylmethyl and monitoring its line broadening caused by oxygen. In this study, the feasibility of EPRI for assessment of oxygen distribution in the glioblastoma using orthotopic U87 and U251 xenograft model. Heterogeneous distribution of pO 2 between 0 and 50 mmHg was observed throughout the tumors except for the normal brain tissue. U251 glioblastoma was more likely to exhibit hypoxia than U87 for comparable tumor size (median pO 2 ; 29.7 mmHg and 18.2 mmHg, P = 0.028, in U87 and U251, respectively). The area with pO 2 under 10 mmHg on the EPR oximetry (HF10) showed a good correlation with pimonidazole staining among tumors with evaluated size. In subcutaneous xenograft model, irradiation was relatively less effective for U251 compared to U87. In conclusion, EPRI is a feasible method to evaluate oxygen distribution in the brain tumor.
Introduction
Glioblastoma (glioblastoma multiforme, GBM) is one subtype of gliomas that arise from glial or precursor cells and the most frequent primary malignant brain tumor in the Unites States with the incidence of 16% among all primary CNS neoplasms [1] . The prognosis of GBM is generally poor with a median survival of approximately 15 months even when treated with optimal therapy [2] . Similar to other malignant tumors, hypoxia is considered one of microenvironmental factors associated with the rapid tumor growth, progression, and resistance to conventional therapies including radiation therapy via an increase in expression of hypoxia-inducible factors (HIFs) [3, 4] . Recently, strategies of hypoxia-targeting cancer therapy such as bioreductive hypoxic toxins and small molecule inhibitors against hypoxia-specific molecular target, have been presented to overcome the refractory state of malignant tumors [5] . Thus, it would be useful for treatment of glioblastomas to evaluate intratumoral distribution of hypoxia for determining the therapeutic planning as well as assessment of its effectiveness during the therapy. In fact, positron emission tomography (PET) with a hypoxic tracer [ 18 F]-FMISO has been proven to be a prospective diagnostic tool for determining tumor aggressiveness in glioma patients and for predicting patient's prognosis [6, 7] . Furthermore, [ 18 F]-FMISO PET also could evaluate the efficacy of the antiangiogenic reagent sunitinib or a hypoxia-activated prodrug evofosfamide (TH-302) and to predict response to them in rat orthotropic glioma models C6 and 9L which show different hypoxic environment [8, 9] . The other hypoxic imaging technique, blood oxygen level-dependent (BOLD) MRI has been implemented in the clinic and relative oxygen extraction fraction (rOEF) map obtained from this method partly reflected the hypoxic tumor region in glioma patient [10] . Both imaging techniques are noninvasive and safe enough to obtain information of tissue oxygenation from patients, but have limitation that they are not capable of absolute oxygen quantification nor necessarily correspond to each other [11] .
Electron paramagnetic resonance imaging (EPRI) is an imaging technique similar to MRI. While MRI detects nuclear spins, EPRI detects unpaired electron spins of free radical species [12] . The EPR spectral line width of the paramagnetic trityl (TAM) is broadened by the collisional interaction with the surrounding dissolved paramagnetic oxygen. This change is proportional to oxygen concentration and can be correlated to absolute pO 2 value, enabling the quantitative oxygen concentration mapping of in vivo tissue. Development of EPR capabilities made it possible to obtain pO 2 maps with resolution of 3 to 4 mm Hg in three dimensions with a spatial resolution of ~1 to 2 mm [13] . Furthermore, establishment of combined system with EPR and MRI, operating at a common frequency such as 300 MHz with the corresponding magnetic fields at 10 mT (EPRI) and 7 T (MRI) enables pO 2 maps with anatomic guidance by sequential scans with the two modalities employing a common resonator [14] . Previous reports showed feasibility of pO 2 mapping created by EPRI in subcutaneous xenograft models using mice [15, 16] . Since many primary intracranial tumors are fed by the blood supply unique to central nervous system and their microvasculature is different from ectopic xenograft model, it might be more practical to assess the intratumoral oxygen level using orthotopic models [17] . Here we present the first study of EPRI for assessment of oxygen distribution in two different glioblastoma lines implanted in the mouse brain. We successfully showed the difference in intratumoral pO 2 map between the two glioblastoma lines and confirmed its validity by comparison to immunohistological findings including a hypoxic probe pimonidazole along with an assessment of anaerobic metabolism-related markers, carbonic anhydrase 9 (CA-IX). were injected subcutaneously into the right hind leg.
Materials and Methods

Chemicals
All animal experiments were carried out in compliance with the Guide for the care and use of laboratory animal resources (National Research Council, 1996) and the experimental protocols were approved by the National Cancer Institute Animal Care and Use Committee.
Imaging experiment
Prior to imaging experiment, mice with an intracranial U87 or U251 tumor were injected with Evans Blue (1%, 200 µL bolus infusion) or OX063 (75 mM, 300 µL bolus infusion) via the tail vein and the excised and sliced brain tissues were observed in the bright field to confirm destruction of brain-blood barrier (BBB) at the tumor region. For the EPR oxygen imaging, a custom-made EPRI scanner was used.
Technical details of the EPRI scanner operating at 500 MHz, radio-frequency (RF) coil design, data acquisition based on the single point imaging (SPI) modality, image reconstruction, and the oxygen mapping procedure have been described in the earlier reports [14, 18, 19, 20, 21] . The mice were imaged immediately after an injection of Inc., Quebec, Canada) and maintained at 36°C±2°C with a flow of warm air for EPR imaging and with a warm water pad for MRI study.
Irradiation and tumor growth study
The experiments were initiated after when the subcutaneous tumors grew to approximately 200 mm 3 in volume (5 -6 mm in diameter). Tumors were irradiated 2 Gy on days 0, 1 and 3 at a dose rate of 280.3 mGy/min (total 6 Gy) using a Pantak (Solon, OH) X-ray source. The animals were restrained without anaesthesia in a custom jig to be irradiated only on the tumor-bearing leg. The tumor size was measured on every 3-4 days with respect to the length, width and height directions by a digital caliper. All the measurements were duplicated to secure the accuracy.
Immunohistochemistry
For the hypoxic staining, pimonidazole (Natural Pharmacia International, Inc., Burlington, MA) was given to tumor-bearing mice intravenously according to the manufacturer's instruction 30 min before excising tumors. Tumor bearing mice were euthanized and perfused with 10 ml of 4 % paraformaldehyde. Tumor tissues were excised from the brain and fixed with 4% paraformaldehyde overnight, frozen with 
Results
Histological and imaging characterization of the glioma cell lines U251 and U87: To define the basic characters of two different glioblastoma cell lines, U87 and U251, MRI and immunohistochemical analyses were performed using orthotopic xenograft models in mice. As assessed by MRI, both tumors had a well-demarcated, high intensity area when compared to the normal brain parenchyma on FSE-T2WI ( Figure 1A) . The findings were similar between the two cell lines with the exception that the U251 tumor also had a higher intensity area surrounding the tumor, suggesting peri-tumoral edema, compared to the U87 tumor. On immunostaining for CA-IX and pimonidazole, the expression of CA-IX was significantly higher in U251 than U87 especially when the tumor size was larger than 50 mm 3 . The CA-IX positive area was 15.9% vs. 2.3%, respectively (P = 0.034, Mann-Whitney's U test), and was less than 3.1% in all the U87 tumors evaluated in this study. The number of pimonidazole-positive cells was constantly higher in the U251 tumors than U87 (19.2% vs 9.1%, respectively; P = 0.012, Mann-Whitney's U test) even when the tumors were relatively small ( Figure 1B and C) .
Although only U87 showed significant correlation between the tumor size and pimonidazole-positive area, apparent positive correlation in U87 and negative correlation in U251 were observed (R = 0.71, P = 0.049 for U87, and R = -0.53, P = 0.17 for U251). These histological studies suggest that the U251 tumor is more hypoxic than the U87.
Tracer distribution in the U251 and U87 tumors: Since effective uptake of the oxygen-sensitive paramagnetic tracer OX063 into the tumor tissue is essential for the oxygen imaging by using EPRI, Evans Blue dye staining was performed to evaluate whether the blood brain barrier (BBB) was intact prior to the EPRI study. The Evans
Blue dye was distributed throughout the tumor tissue in both tumor cell lines, indicating impairment of the BBB at the tumor site (Figure 2A, left) . Similarly, distribution of OX063, which is green-colored reagent, was confirmed by macroscopical observation and intensity image of EPRI (Figure 2A, right and B) . In contrast, the tracer was not distributed in the normal brain tissue, where BBB functioned properly ( Figure 2B ).
These results show that OX063 accumulates in the orthotopic tumors at adequate levels to permit quantitative assessment of tumor pO 2 .
Oxygen mapping by EPR Imaging: To investigate the difference in hypoxic status within the U87 and U251 orthotopic tumors, non-invasively, the spatial distribution of oxygen in the tumor-bearing mouse brain was examined using EPRI after administration of OX063 via the tail vein. Figure 3A shows axial (upper panel) and coronal (lower panel) planes of the oxygen maps from EPRI. These had a corresponding slice of 1-mm thickness T2-weighted MR image overlayed to give anatomical details.
To assure accuracy of the cross-sectional locations between images from the two modalities, we use a sequential EPRI and MRI imaging system as described previously [14] . Heterogeneous distribution of pO 2 was observed in the range between 0 and 50 mmHg throughout the U87 and U251 tumors as well as the extracranial tissue except for the normal brain tissue. On the two-dimensional image where the size of the tumor section was largest, median pO 2 and the ratio of hypoxic area, where pO 2 was less than 10 mmHg (HF10) within the tumor were calculated to characterize tumor oxygen status for the two cell lines. The dot plot of HF10 against tumor volume suggest that the U251 glioblastoma was more hypoxic than U87 tumor in agreement with pimonidazole staining (Median pO 2 , 29.7 mmHg (U87) vs. 18.2 mmHg (U251), P = 0.028, Mann-Whitney's U test). There was a significant positive correlation between the tumor size and HF10 in U251 (R = 0.94, P = 0.016) ( Figure 3B ).
Growth delay by XRT:
To investigate the growth suppression effects of irradiation, subcutaneous xenograft tumor model was examined rather than the orthotopic tumor because it was possible to observe the tumor volume continuously until the tumor grew adequately large to evaluate. At 15 days (U87) or 4 days (U251) after an injection of tumor cell suspension, the tumor volume was calculated. Thereafter, the tumor was irradiated with 2 Gy dose per fraction for three consecutive days followed by measurement of the tumor size at every two to three days (Figure 4 ). To compensate different growth rate between the two cell lines by nature, the radioresponse ratio (relative growth delay) was calculated using the following equation:
Relative growth delay = [Days required to grow 500 mm 3 in X-rays group] /
[ Days required to grow 500 m 3 
in control group]
There was no significant difference in the tumor volume between the two lines and groups at the time point when the first irradiation was performed (P = 0.786). Tumor growth suppression was observed for both of the tumors compared to each non-irradiated control group, respectively. The relative growth delay was greater for U87 than U251 although the absolute delay was shorter for U87 than U251 (Table 1) .
Discussion
To overcome the aggressive characteristics and therapeutic resistance that tumors acquire under hypoxic state within the intratumoral microenvironment is important [22, 23] . In clinical settings, evaluation of tumor hypoxia prior to treatment might be beneficial for designing optimal therapeutic strategies suitable for tumors in different oxygenation conditions. Previous studies showed potential effectiveness of dose escalation radiation therapy using [ 18 F]-FMISO PET to assess tumor hypoxia [24, 25] .
The measurement of absolute pO 2 using [ 18 F]-FMISO PET, however, is not still sufficient to make quantitative delineations of hypoxic regions inside the tumor; this limitation might make it difficult to plan precisely for dose-modulation radiation therapy [26, 27] . On the other hand, a strong potential of EPRI for detection and quantitation of tumor hypoxia has also been shown using subcutaneous xenograft models in previous preclinical studies [14, 28] . EPRI is considered to have advantages over PET in some points where it is able to 1) measure pO 2 deep in tissue without radioisotopes, 2) to provide absolute pO 2 values with resolution of 3-4 mm Hg, and 3) is capable to obtain three-dimensional images of fluctuating oxygenation every 2-3 minutes with 1-2 mm spatial resolution.
In this study, we evaluated feasibility of EPRI for detecting hypoxic region in brain tumors by using an orthotopic xenograft mouse model and correlated the obtained pO 2 maps to histochemical findings of hypoxyprobe pimonidazole and CA-IX. CA-IX is one of the downstream proteins induced by HIF-1α and plays an essential role for maintaining intracellular pH under the metabolic shift to anaerobic glycolysis in hypoxic circumstances [29, 30] . We employed CA-IX as an indirect hypoxic marker because its expression has been reported to closely correlate with tumor oxygenation by direct measurements using polarography [31, 32] . Besides, the amount of HIF-1α protein may not necessarily relate to oxygen level because its activity is tightly regulated, not only by rapid turnover when oxygen is abundant, but also by posttranslational modifications [33] .
Pimonidazole is a widely-used hypoxic marker that binds to thiol-containing proteins specifically in hypoxic (pO 2 < 10 mmHg) cells and retains over hours in the tissue [34, 35, 36] . In general, BBB restricts the transport of hydrophilic or high molecular drugs into the brain to maintain the brain internal milieu and influences their distribution when we consider in vivo imaging of intracranial lesions using contrast materials [37, 38] . In previous reports, acceptable distribution of pimonidazole in the brain tumor as well as normal brain tissue has been described both in orthotopic xenograft models and human patients, indicating pimonidazole enters brain tissue through BBB [39, 40] . On the other hand, trityl OX063, a radical species used as a contrast agent for EPRI is a water-soluble large molecule (molecular mass; 1427) and its permeability through BBB remains unknown [41] . Generally, small (< 400 Da) nonpolar lipophilic agents are easily transported passively across the BBB, whereas hydrophilic compounds require active transport mechanisms [42, 43] . On the other hand, in many advanced malignant gliomas, disruption of the BBB was reported [44, 45] . The extravasation test of evans blue dye, which is known to bind to albumin producing a 68 kDa compound that does not cross the BBB [46] , clearly showed that the leakage of evans blue dye into the tumor region compared to normal brain tissue, indicating the BBB disruption in both U87 and U251 intracranial tumors. Consistent with this observation, OX063 also showed a good distribution in the both tumors. This finding was consisted with the spin images derived from the incorporated OX063 on EPRI, suggested its validity for use of EPRI oximetry at least in these tumor lines.
In the histological experiments, pimonidazole staining showed constantly higher in the ratio of positive areas within U251 than those within U87 except one tumor (Fig 1c, U87 in size 113.4 mm 3 ) . Especially, the difference was more prominent when the tumor volume was small (< 10 mm 3 ). This finding along with our imaging finding on T2WI MRI was consistent with a former report that showed U87 xenografts were less infiltrative and exhibited profuse neovascularization without necrosis or hemorrhages compared to U251 [47] . Additionally, previous data that showed the density of microvasculature within the tumor as well as the expression level of VEGF were higher in U87 than U251 might also support our findings [48, 49] . Similarly, the expression of CA-IX in U251 was significantly higher than U87 when tumor volume was larger than 30 mm 3 . In contrast to the pimonidazole staining, however, the expression of CA-IX remained low level in the both tumor lines when the tumor volume was small (< 20 mm 3 ).
Rademakers et al. reported in their histochemical study of biopsy samples from human
head and neck carcinomas that there were CA-IX-negative areas in pimonidazole staining area even though there was a correlation between the expression of these proteins [50] .
Harada et al. also reported a discrepancy between pimonidazole-positive area and HIF-1α expression level and that this is because HIF-1α was dominantly suppressed in severe hypoxic and low-glucose area [51] . Combined with these knowledge, although still unclear, our results of CA-IX can be explained by assuming that an early-stage U251 tumor with smaller size has not developed enough tumor vessels so that severe hypoxic area was dominant and thus both HIF-1α and CA-IX expression remained low even in the pimonidazole-negative areas. Similarly, the case with pimonidazole-positive and low CA-IX-positive tumor in U87 could also be explained by those previous data. In contrast, HF10, area with pO 2 under 10 mmHg on the EPR oximetry showed a similar tendency to pimonidazole staining among tumors with evaluated size. Especially, HF10 area in U87 on EPRI became higher in parallel with the increase in pimonidazole-positive area. There was also positive correlation between HF10 and the tumor size, consistent with former literature investigating hypoxic area using a modified comet assay [52] .
Radiation sensitivity of these tumor lines was different in our subcutaneous xenograft model. The finding that U251 was more resistant to irradiation than U87 was reasonable in view of the result where hypoxic area was more dominant in the U251 tumor both in EPRI and pimonidazole findings. We employed the subcutaneous model which was of advantage that tumors could be tracked until they grow to relatively large size. However, the tumor sizes of both xenografts when the irradiation was performed were relatively large as about 150 mm 3 ; the formation of hypoxic region could occur in U87 tumor to some extent. This might influence the small difference of radioresponse ratio between two cell lines (1.45 for U87 vs 1.29 for U251). There were some limitations to be mentioned. First, it remained still unclear whether tumors without BBB disruption could be detected by EPRI. Although Shen et al. reported EPRI for brain ischemia using another radical compound that can cross BBB, there were also some limitations in sensitivity for pO 2 and its acquisition time [53] . Second, since this study did not compare EPRI findings and histochemistry in one-to-one manner, the exact localization of hypoxic areas on EPRI was not achieved. Third, a possibility of hypoxia-independent pimonidazole staining has been reported in some differentiated tumors especially in the region where reductive enzyme levels are elevated [54] . Fourth, small size tumors were not investigated on EPRI because of its limitation in spatial resolution. Nevertheless, a previous study using subcutaneous xenograft model successfully showed correlations between the extent of hypoxia on EPRI pO 2 map and expression patterns of HIF-1α, suggesting this method could also be used for hypoxia mapping in the intracranial tumor [16] . Lastly, it has also been described the benefits of EPRI for investigating tumor metabolism by using along with other imaging modalities such as dynamic nuclear polarized MRI [55] . In conclusion, this is the first report that showed a feasibility of EPRI for the brain tumor using orthotopic brain tumor model and might provide not only information of malignancy or sensitivity to treatment but also help us obtain useful knowledge in metabolism of brain tumors that leads to more effective therapeutic strategies and excellent outcome. 
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